# Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation

> **NCT00811915** · PHASE3 · TERMINATED · sponsor: **University Hospital, Rouen** · enrollment: 65 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00811915
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Difficulty in enrolling new patients
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811915, "Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00811915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*